MEDI CAPS LTD.
Medi Caps Ltd. (MEDICAPQ): company summary
The company's business has deteriorated significantly, with annual revenue falling 51.1% and annual net profit turning into a loss that widened from ₹1 crore to ₹3 crore.
Medi Caps Ltd. (MEDICAPQ) is a micro-cap Healthcare company valued at ₹31 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Medi Caps Ltd. last traded at ₹25.7, modestly down 1.12% on the day.
- Recent developments
- 2026-09-30: Promoter holding remained at 51.44%, indicating no change in ownership structure. 2026-06-30: The company reported a net loss of ₹2 crore for the latest quarter, reflecting a narrowing loss compared to the prior quarter's ₹3 crore.
- Financial performance
- The company's business has deteriorated significantly, with annual revenue falling 51.1% and annual net profit turning into a loss that widened from ₹1 crore to ₹3 crore. The latest quarter shows a slight improvement, with net profit loss narrowing from ₹3 crore to ₹2 crore, though revenue remained flat compared to the same quarter a year earlier.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 0.39 times book value.
- Things to watch
- The company reported a net loss of ₹3 crore in its latest financial year, with net profit margin worsening to -24.4% from -2.2% a year earlier. The latest quarter's net loss of ₹2 crore, while narrower than the prior quarter, highlights ongoing profitability challenges.
- Where it stands
- The company continues to operate at a loss, with net profit margin deteriorating sharply and annual net profit turning into a loss that widened. The latest quarter's net loss of ₹2 crore marks a slight improvement, but the overall financial position remains weak.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (7.5) and valuation (6.0), but held back by quality (0.0). Growth looks strong at 7.5, but that is offset by quality at 0.0 and momentum at 2.5. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Revenue compounding 399% a year
- Low leverage — D/E 0.00
- Loss-making — no meaningful P/E
- Loss-making in some of the last 5 years
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore MEDI CAPS LTD.’s valuation
Free deep-dive tools · no sign-up
MEDI CAPS LTD. peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Related tools & concepts
Value MEDI CAPS LTD. with the ratios and calculators DocStoX uses in its analysis.

